The Kislinger Laboratory is located at the Princess Margaret Cancer Research Tower of the Princess Margaret Cancer Centre, the largest oncology treatment and research facility in Canada. The major goal of our lab is to apply proteomics technologies to cancer and cardiovascular research. Our research interests include technology development, using the latest generation of mass spectrometry instrumentation, basic cell biology and translational cancer research.
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands.
Nat Genet. 2014 Nov;46(11):1166-9
Nat Cell Biol. 2014 Sep;16(9):889-901
Mol Cell Proteomics. 2014 Aug 21;
Eur J Neurol. 2014 Aug 7;
Identification of a BET family bromodomain/casein kinase II/TAF-containing complex as a regulator of mitotic condensin function.
Cell Rep. 2014 Mar 13;6(5):892-905
Expert Rev Proteomics. 2014 Apr;11(2):167-77
Proteomic profiles of human lung adeno and squamous cell carcinoma using super-SILAC and label-free quantification approaches.
Proteomics. 2014 Mar;14(6):795-803
In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome.
Biochem Biophys Res Commun. 2014 Mar 21;445(4):694-701
Qualitative changes in the proteome of extracellular vesicles accompanying cancer cell transition to mesenchymal state.
Exp Cell Res. 2013 Oct 15;319(17):2747-57
Genome Med. 2013;5(6):56
Senior Scientist, Princess Margaret Cancer Centre